Personal tools

MCL coexpression mm9:1862: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002193!2.96e-17!48;UBERON:0002405!2.96e-17!48;UBERON:0002390!1.85e-16!45;UBERON:0003061!1.85e-16!45;UBERON:0003081!5.54e-11!87;UBERON:0000077!5.17e-10!35;UBERON:0004177!5.70e-10!29;UBERON:0005057!5.70e-10!29;UBERON:0001041!1.14e-09!80;UBERON:0005911!1.77e-08!69;UBERON:0003929!5.19e-08!55;UBERON:0000926!8.27e-08!120;UBERON:0004120!8.27e-08!120;UBERON:0006603!8.27e-08!120;UBERON:0003408!8.66e-08!24;UBERON:0001474!1.17e-07!22;UBERON:0004765!1.17e-07!22;UBERON:0001434!1.17e-07!22;UBERON:0002370!1.42e-07!23;UBERON:0000974!1.42e-07!23;UBERON:0004807!1.42e-07!23;UBERON:0005058!1.42e-07!23;UBERON:0003351!1.42e-07!23;UBERON:0009113!1.42e-07!23;UBERON:0003295!1.42e-07!23;UBERON:0009722!1.42e-07!23;UBERON:0005562!1.42e-07!23;UBERON:0007690!1.42e-07!23;UBERON:0000490!1.59e-07!66;UBERON:0006562!1.71e-07!24;UBERON:0001557!1.71e-07!24;UBERON:0001042!1.71e-07!24;UBERON:0008814!1.71e-07!24;UBERON:0009145!1.71e-07!24;UBERON:0002371!2.00e-07!16;UBERON:0002530!2.48e-07!65;UBERON:0002204!3.23e-07!32;UBERON:0002384!3.38e-07!46
|ontology_enrichment_uberon=UBERON:0002193!2.96e-17!48;UBERON:0002405!2.96e-17!48;UBERON:0002390!1.85e-16!45;UBERON:0003061!1.85e-16!45;UBERON:0003081!5.54e-11!87;UBERON:0000077!5.17e-10!35;UBERON:0004177!5.70e-10!29;UBERON:0005057!5.70e-10!29;UBERON:0001041!1.14e-09!80;UBERON:0005911!1.77e-08!69;UBERON:0003929!5.19e-08!55;UBERON:0000926!8.27e-08!120;UBERON:0004120!8.27e-08!120;UBERON:0006603!8.27e-08!120;UBERON:0003408!8.66e-08!24;UBERON:0001474!1.17e-07!22;UBERON:0004765!1.17e-07!22;UBERON:0001434!1.17e-07!22;UBERON:0002370!1.42e-07!23;UBERON:0000974!1.42e-07!23;UBERON:0004807!1.42e-07!23;UBERON:0005058!1.42e-07!23;UBERON:0003351!1.42e-07!23;UBERON:0009113!1.42e-07!23;UBERON:0003295!1.42e-07!23;UBERON:0009722!1.42e-07!23;UBERON:0005562!1.42e-07!23;UBERON:0007690!1.42e-07!23;UBERON:0000490!1.59e-07!66;UBERON:0006562!1.71e-07!24;UBERON:0001557!1.71e-07!24;UBERON:0001042!1.71e-07!24;UBERON:0008814!1.71e-07!24;UBERON:0009145!1.71e-07!24;UBERON:0002371!2.00e-07!16;UBERON:0002530!2.48e-07!65;UBERON:0002204!3.23e-07!32;UBERON:0002384!3.38e-07!46
|tfbs_overrepresentation_for_novel_motifs=0.641384,0.801438,0.612053,0.688265,1.21364,0.704257,0.803568,0.370124,0.381467,0.162942,0.755749,0.790506,0.37041,0.81685,0.502646,0,1.02248,0.473993,0.352304,0.24402,0.570433,0.197567,0.815872,0.481455,0.620553,0.846564,0.342316,0.727368,0.535752,0.290745,0.711848,1.12823,0.471365,0.318879,1.2563,0.089443,0.460474,0.786577,0.434783,0.40068,0.478558,0.717547,0.185353,0.504971,0.0986756,0.675898,0.938241,0.744678,0.162985,0.539131,1.0041,0.875451,0.282443,1.2746,1.29252,0.82458,0.549352,0.776619,0.331485,0.822375,1.10737,0.885556,0.39557,0.992216,0.8366,1.03484,1.43193,1.78579,1.1025,1.63712,0.590754,0.377213,0.205546,1.32691,0.323563,0.310084,0.318792,0.926147,1.08947,0.575233,0.986898,1.04072,0.884013,0.362446,1.20828,0.377699,0.40635,0.290918,0.943446,1.94914,1.50286,1.21342,1.14153,0.490141,0.430015,0.409166,0.961641,1.14445,0.938512,0.264911,0.460566,1.12793,1.25667,1.00472,1.00361,0.717061,1.06633,0.740267,0.580757,1.4032,0.633483,1.25851,0.576517,0.7614,1.51002,0.476467,0.143825,0.692434,1.02384,0.456123,1.33244,2.22508,0.848526,0.925183,1.56496,1.09333,0.812403,1.13449,1.43038,0.493609,1.23918,0.680176,1.40022,0.839311,1.53196,0.195549,1.56752,0.719099,1.482,2.31884,1.91709,1.43673,0.861473,1.1391,0.996781,0.718046,0.941555,2.27909,0.653418,0.485304,0.293812,0.184289,1.27621,0.416214,0.838313,1.35996,0.87653,0.516549,0.63863,0.650472,1.49167,1.20739,1.09379,0.630949,0.993294,0.830321,0.459159,0.788782,0.280875
}}
}}

Revision as of 20:32, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:110601850..110601867,+p1@Osbpl8
Mm9::chr1:173770688..173770701,+p4@Cd84
Mm9::chr1:173770738..173770772,+p1@Cd84
Mm9::chr2:3341395..3341479,+p1@Dclre1c


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0000014single-stranded DNA specific endodeoxyribonuclease activity0.0129841669862488
GO:00084095'-3' exonuclease activity0.0324533040229507
GO:0004520endodeoxyribonuclease activity0.0340461036786531
GO:0032200telomere organization and biogenesis0.0340461036786531
GO:0000723telomere maintenance0.0340461036786531
GO:0004536deoxyribonuclease activity0.0340461036786531
GO:0006302double-strand break repair0.0340461036786531
GO:0010212response to ionizing radiation0.0340461036786531



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
hemolymphoid system2.96e-1748
immune system2.96e-1748
hematopoietic system1.85e-1645
blood island1.85e-1645
lateral plate mesoderm5.54e-1187
mixed endoderm/mesoderm-derived structure5.17e-1035
hemopoietic organ5.70e-1029
immune organ5.70e-1029
foregut1.14e-0980
endo-epithelium1.77e-0869
gut epithelium5.19e-0855
mesoderm8.27e-08120
mesoderm-derived structure8.27e-08120
presumptive mesoderm8.27e-08120
gland of gut8.66e-0824
bone element1.17e-0722
skeletal element1.17e-0722
skeletal system1.17e-0722
thymus1.42e-0723
neck1.42e-0723
respiratory system epithelium1.42e-0723
hemolymphoid system gland1.42e-0723
pharyngeal epithelium1.42e-0723
thymic region1.42e-0723
pharyngeal gland1.42e-0723
entire pharyngeal arch endoderm1.42e-0723
thymus primordium1.42e-0723
early pharyngeal endoderm1.42e-0723
unilaminar epithelium1.59e-0766
pharynx1.71e-0724
upper respiratory tract1.71e-0724
chordate pharynx1.71e-0724
pharyngeal arch system1.71e-0724
pharyngeal region of foregut1.71e-0724
bone marrow2.00e-0716
gland2.48e-0765
musculoskeletal system3.23e-0732
connective tissue3.38e-0746


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}